A Clinical trial on Thirikandagathi kiyaazham in the treatment of Kalladaippu among patients attending OPD, Government Siddha Medical College, Palayamkottai

A CASE SERIES ON ASSESSMENT OF EFFECTIVENESS OF THIRIKANDAGATHI KIYAAZHAM IN THE TREATMENT OF KALLADAIPPU (UROLITHIASIS) AMONG PATIENTS ATTENDING OPD, GOVERNMENT SIDDHA MEDICAL COLLEGE AND HOSPITAL, PALAYAMKOTTAI - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/102786

Enrollment

Registered

2026-02-02

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N20- Calculus of kidney and ureter

Interventions

Intervention1: Thirikandagathi kiyaazham: DOSAGE:50ml Twice a day orally for 40 days Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: Size of the renal stone-less than 10mm confirmed by USG Renal colicky pain (loin to groin pain) Oliguria Dysuria Haematuria Nausea and vomiting

Exclusion criteria

Exclusion criteria: Chronic kidney disease Pelvic inflammatory disease Pyelonephritis Appendicitis Associated with Metabolic disorders Pregnancy& lactating women

Design outcomes

Primary

Measure	Time frame
The outcome will be aimed at reducing the symptoms of Kalladaippu-Urolithiasis and the kidney stone is expelled to come out or be disintegrated and mixed with urine will be ensured and to determine the therapeutic efficacy of clinical trial drug(Thirikandagathi kiyaazham)Timepoint: 40 days	—

Secondary

Measure	Time frame
The secondary outcome will be aimed at reducing the size of the kidney stone in USG Abdomen and pelvisTimepoint: 40 days	—

Countries

India

Contacts

Public ContactDr S JUSTUS ANTONY

Government Siddha Medical College and Hospital

siddhadrgs21@gmail.com9345600723

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026